nach oben

Erschienen in:

13.06.2017 | Original Paper

Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012

verfasst von: Kalysha Closson, Chuck Osborne, Danielle M. Smith, Sarah Kesselring, Oghenowede Eyawo, Kiffer Card, Paul Sereda, Shahab Jabbari, Conrado Franco-Villalobos, Tareq Ahmed, Karyn Gabler, Thomas Patterson, Mark Hull, Julio S. G. Montaner, Robert S. Hogg, for The Comparative Outcomes and Services utilization Trends (COAST) study

Erschienen in: AIDS and Behavior | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Using data from the Comparison of Outcomes and Service Utilization Trends (COAST) study we examined factors associated with mood disorder diagnosis (MDD) among people living with HIV (PLHIV) and HIV-negative individuals in British Columbia, Canada. MDD cases were identified between 1998 and 2012 using International Classification of Disease 9 and 10 codes. A total of 491,796 individuals were included and 1552 (23.7%) and 60,097 (12.4%) cases of MDD were identified among the HIV-positive and HIV-negative populations, respectively. Results showed HIV status was associated with greater odds of MDD among men and lower odds among women. Among PLHIV, MDD was significantly associated with: identifying as gay, bisexual or other men who have sex with men compared to heterosexuals; higher viral load; history of injection drug use; and concurrent anxiety, dysthymia, and substance use disorders. Findings highlight the need for comprehensive and holistic HIV and mental health care.

Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE. 2013;8:e81355.CrossRefPubMedPubMedCentral

Patterson S, Cescon A, Samji H, et al. Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada. BMC Infect Dis. 2015;15:274.CrossRefPubMedPubMedCentral

Garey L, Bakhshaie J, Sharp C, et al. Anxiety, depression, and HIV symptoms among persons living with HIV/AIDS: the role of hazardous drinking. AIDS Care. 2015;27:80–5.CrossRefPubMed

Magidson JF, Blashill AJ, Safren SA, et al. Depressive symptoms, lifestyle structure, and ART adherence among HIV-infected individuals: a longitudinal mediation analysis. AIDS Behav. 2015;19:34–40.CrossRefPubMedPubMedCentral

Nanni MG, Caruso R, Mitchell AJ, et al. Depression in HIV infected patients: a review. Curr Psychiatry Rep. 2015;17:530.CrossRefPubMed

Salters KA, Irick M, Anema A, et al. Harder-to-reach people living with HIV experiencing high prevalence of all-type mental health disorder diagnosis. AIDS Care. 2016;. doi:10.1080/09540121.2016.1227763.PubMed

Hanel G, Henningsen P, Herzog W, et al. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study. J Psychosom Res. 2009;67:189–97.CrossRefPubMed

Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10:e1001547.CrossRefPubMedPubMedCentral

Challacombe L. The epidemiology of HIV in Canada. Available at: http://www.catie.ca/en/fact-sheets/epidemiology/epidemiology-hiv-canada.

10.

Public Health Agency of Canada. What is Depression?. Available at: http://www.phac-aspc.gc.ca/cd-mc/mi-mm/depression-eng.php Accessed 20 Apr 2016.

11.

Statistics Canada. Mood disorders by sex, by province and territory Government of Canada, 2016.

12.

Lima VD, Geller J, Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS. 2007;21:1175–83.CrossRefPubMed

13.

Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372:1733–45.CrossRefPubMed

14.

Taniguchi T, Shacham E, Onen NF, et al. Depression severity is associated with increased risk behaviors and decreased CD4 cell counts. AIDS Care. 2014;26:1004–12.CrossRefPubMedPubMedCentral

15.

Eyawo O, Franco-Villalobos C, Hull MW, et al. Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012. BMC Infect Dis. 2017;17:174.CrossRefPubMedPubMedCentral

16.

BC Centre for Excellence in HIV/AIDS. Drug Treatment Program and Labratory Available at:. http://www.cfenet.ubc.ca/drug-treatment-program and http://www.cfenet.ubc.ca/research/laboratory-program.

17.

Population Data BC: About Population Data BC. Available at: http://www.popdata.bc.ca/aboutus Accessed 31 Mar 2017.

18.

Kisely S, Lin E, Gilbert C, et al. Use of administrative data for the surveillance of mood and anxiety disorders. Australian and New Zeland Journal of Psychiatry. 2009;43:1118–25.CrossRef

19.

Puyat JH, Marhin WW, Etches D, et al. Estimating the prevalence of depression from EMRs. Canadian Family Psysician. 2013;59:445.

20.

British Columbia Ministry of Health (2014): Consolidation File (MSP Registration & Premium Billing). Population Data BC. Data Extract. MOH (2014). http://www.popdata.bc.ca/data.

21.

British Columbia Ministry of Health (2014): Medical Services Plan (MSP) Payment Information File. Population Data BC. Data Extract. MOH (2014). http://www.popdata.bc.ca/data.

22.

Canadian Institute for Health Information (2014): Discharge Abstract Database (Hospital Separations). Population Data BC. Data Extract. MOH (2014). http://www.popdata.bc.ca/data.

23.

BC Vital Statistics Agency (2014): Vital Statistics Deaths. Population Data BC. Data Extract. BC Vital Statistics Agency (2014). http://www.popdata.bc.ca/data.

24.

Hayashi K, Dong H, Marshall BD, et al. Sex-based differences in rates, causes, and predictors of death among injection drug users in Vancouver, Canada. Am J Epidemiol. 2016;183:544–52.CrossRefPubMedPubMedCentral

25.

R Core Team. R: A language and environemnt for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2015.

26.

Arseniou S, Arvaniti A, Samakouri M. HIV infection and depression. Psychiatry Clin Neurosci. 2014;68:96–109.CrossRefPubMed

27.

Lopes M, Olfson M, Rabkin J, et al. Gender, HIV status, and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2012;73:384–91.CrossRefPubMed

28.

Heywood W, Lyons A. HIV and Elevated Mental Health Problems: Diagnostic, Treatment, and Risk Patterns for Symptoms of Depression, Anxiety, and Stress in a National Community-Based Cohort of Gay Men Living with HIV. AIDS Behav. 2016;20:1632–45.CrossRefPubMed

29.

Pettes T, Kerr T, Voon P, et al. Depression and sexual risk behaviours among people who inject drugs: a gender-based analysis. Sexual Health. 2015;12:224–30.PubMedPubMedCentral

30.

Joint United Nations Programme on HIV/AIDS. Global AIDS update 2016. Geneva: UNAIDS, 2016

31.

Gardner LI, Marks G, Shahani L, et al. Assessing efficacy of a retention in care intervention among HIV patients with depression, anxiety, heavy alcohol consumption and illicit drug use. Aids. 2016;30:1111–9.CrossRefPubMed

32.

Socias ME, Koehoorn M, Shoveller J. Gender Inequalities in Access to Health Care among Adults Living in British Columbia, Canada. Womens Health Issues. 2016;26:74–9.CrossRefPubMed

33.

Public Health Agency of Canada (PHAC). Population-Specific HIV/AIDS Status Report: Women; 2012 October 31st, 2016.

34.

Asch SM, Kilbourne AM, Gifford AL, et al. Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med. 2003;18:450–60.CrossRefPubMedPubMedCentral

35.

Greenberg PE, Fournier AA, Sisitsky T, et al. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76:155–62.CrossRefPubMed

36.

Lepine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat. 2011;7:3–7.PubMedPubMedCentral

37.

Sherr L, Clucas C, Harding R, et al. HIV and depression–a systematic review of interventions. Psychol Health Med. 2011;16:493–527.CrossRefPubMed

38.

Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. JAMA. 2001;285:1466–74.CrossRefPubMed

39.

Griffiths H Dr. Peter Centre—removing barriers to health care services. Nurs BC. 2002;34:10–4.PubMed

40.

Kalichman SC, Rompa D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nerv Ment Dis. 2000;188:662–70.CrossRefPubMed

41.

Haut ER, Pronovost PJ. Surveillance bias in outcomes reporting. JAMA. 2011;305:2462–3.CrossRefPubMed

42.

HealthMeasures: Transforming how health is measured. Available at: http://www.healthmeasures.net/explore-measurement-systems/promis Accessed 18 Mar 2017.

43.

Pakula B, Shoveller JA. Sexual orientation and self-reported mood disorder diagnosis among Canadian adults. BMC Public Health. 2013;13:209.CrossRefPubMedPubMedCentral

44.

World Health Organization. Classifications of Disease. Available at: http://www.who.int/classifications/icd/en/Accessed 30 Mar 2017.

Titel: Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012
verfasst von: Kalysha Closson
Chuck Osborne
Danielle M. Smith
Sarah Kesselring
Oghenowede Eyawo
Kiffer Card
Paul Sereda
Shahab Jabbari
Conrado Franco-Villalobos
Tareq Ahmed
Karyn Gabler
Thomas Patterson
Mark Hull
Julio S. G. Montaner
Robert S. Hogg
for The Comparative Outcomes and Services utilization Trends (COAST) study
Publikationsdatum: 13.06.2017
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 5/2018
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-017-1825-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Depressive Symptoms, Alcohol and Drug Use, and Physical and Sexual Abuse Among Men Who Have Sex with Men in Kisumu, Kenya: The Anza Mapema Study

Loneliness in Older Adults Living with HIV

Psychopathology Subgroups and HIV Risk Among Women in Psychiatric Treatment

A Cross-Sectional Study of Depressive Symptoms and Risky Alcohol Use Behaviors Among HIV Primary Care Patients in New York City

Patient-Initiated Repackaging of Antiretroviral Therapy, Viral Suppression and Drug Resistance

Association Between Depressive Symptom Patterns and Clinical Profiles Among Persons Living with HIV

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin